EUVIMEDEUVIMED entdecken
Crossref

Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience

Gal Rubinstein iD, Andrea Fernandez Valledor, Cathrine M Moeller iD, Julia Baranowska, Daniel Oren iD, David Kyung Taek Oh, David Bae, Adil Yunis, Dor Lotan iD, Afsana Rahman iD, Jayant K Raikhelkar iD, Justin A Fried und 5 weitere

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Gal Rubinstein und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Photopheresis, Graft Rejection, Heart Transplantation, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extracorporeal photopheresis (ECP) has gained recognition as a valuable adjunctive antirejection therapy, particularly in heart‐transplantation (HT) patients at elevated risk for rejection or those experiencing recurrent antibody‐mediated rejection (AMR) despite appropriate treatment. We evaluated the safety and clinical effects of ECP in HT recipients with high immunologic risk.

Methods

All HT recipients who underwent ECP between February 2020 and January 2024 were included in this retrospective, single‐center study.

Results

Fifteen patients who underwent ECP were identified. Twelve patients completed ECP and were followed for a median of 11.2 months (3.9–19.9). The time from transplant to ECP initiation was 5.3 years (1.3–13). The most common indication for ECP was AMR (60%). During ECP, immunosuppression regimens were maintained or de‐escalated in 93% of the patients. Reduction in donor specific antibodies (DSA), peripheral gene expression profiling (GEP), and donor‐derived cell‐free DNA (dd‐cfDNA) levels were observed in 64%, 57%, and 67% of the patients, respectively. Eighty‐three percent of the patients were free from rejection during the follow‐up period. Overall survival was 87%, and no deaths were related to ECP.

Conclusion

In our single‐center experience, ECP resulted in a decrease in immunosuppression use, and a reduction in DSA, GEP, and dd‐cfDNA levels with a high freedom‐from‐rejection rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotopheresisGraft RejectionHeart TransplantationPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedFollow-Up StudiesGraft SurvivalPrognosisAdultRisk FactorsSurvival Rate

Stichwörter der Autor:innen

ECPextracorporeal photopheresisheart transplantationrejection

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiology, New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
  • University of Barcelona (UB), Barcelona, Spain.

ORCID-Profile: Gal Rubinstein, Cathrine M Moeller, Daniel Oren, Dor Lotan, Afsana Rahman, Jayant K Raikhelkar, Ersilia M DeFilippis, Kevin J Clerkin

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Rubinstein, G., Valledor, A. F., Moeller, C. M., Baranowska, J., Oren, D., Oh, D. K. T., Bae, D., Yunis, A., Lotan, D., Rahman, A., Raikhelkar, J. K., Fried, J. A., DeFilippis, E. M., Clerkin, K. J., Latif, F., Sayer, G. T., & Uriel, N. (2025). Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience. Clinical Transplantation. https://doi.org/10.1111/ctr.70247

Vancouver

Rubinstein G, Valledor AF, Moeller CM, Baranowska J, Oren D, Oh DKT, et al. Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience. Clinical Transplantation. 2025. doi:10.1111/ctr.70247

BibTeX
@article{Rubinstein2025,
  author = {Rubinstein, Gal and Valledor, Andrea Fernandez and Moeller, Cathrine M and Baranowska, Julia and Oren, Daniel and Oh, David Kyung Taek and Bae, David and Yunis, Adil and Lotan, Dor and Rahman, Afsana and Raikhelkar, Jayant K and Fried, Justin A and DeFilippis, Ersilia M and Clerkin, Kevin J and Latif, Farhana and Sayer, Gabriel T and Uriel, Nir},
  title = {Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70247}
}
Kostenlos starten →